SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,781.76 -120.83
( -0.16%)

Global Indices

Nasdaq

52,089.49 -312.17
(-0.60%)

Dow Jones

7,612.71 -44.65
(-0.58%)

Hang Seng

63,979.83 -1,291.12
(-1.98%)

Nikkei 225

10,611.90 -58.16
(-0.55%)

Forex

USD-INR

95.06 0.32
(0.34%)

EUR-INR

110.60 0.49
(0.45%)

GBP-INR

128.80 0.53
(0.41%)

JPY-INR

0.62 0.00
(0.59%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Natco Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524816

INE987B01026

477.507017

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATCOPHARM

16.45

14669.1

EPS(TTM)

Face Value()

Div & Yield %

49.8

0.61

Back

NCL Research and Financial Services board to consider terms of rights issue

Aug 17,2026

The board of NCL Research and Financial Services will meet on 21 August 2026 to consider and approve terms of proposed rights issue.

74,781.76 -120.83 ( -0.16%)

52,089.49 -312.17 (-0.60%)

7,612.71 -44.65 (-0.58%)

63,979.83 -1,291.12 (-1.98%)

10,611.90 -58.16 (-0.55%)

95.06 0.32 (0.34%)

110.60 0.49 (0.45%)

128.80 0.53 (0.41%)

0.62 0.00 (0.59%)